http://rdf.ncbi.nlm.nih.gov/pubchem/patent/JP-H0283384-A

Outgoing Links

Predicate Object
assignee http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_a8659631bf38b3a590c0d3edc265492c
classificationCPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P9-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D417-12
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P3-08
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P3-06
classificationIPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D277-34
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D417-12
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P3-08
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-426
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-425
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D263-58
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-496
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-505
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-44
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D277-20
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P9-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P3-06
filingDate 1989-08-25-04:00^^<http://www.w3.org/2001/XMLSchema#date>
inventor http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_5a1184763171d12348baabc7c88f25bd
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_6d115b322f1a0a438d070976e5f3524b
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_ae88ff4a904676e4d1c8d6eb8f299e78
publicationDate 1990-03-23-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationNumber JP-H0283384-A
titleOfInvention Novel compound, its production and pharmaceutical composition containing the same
abstract NEW MATERIAL: A compd. represented by formula I {wherein A 1 is a (substituted) aromatic heterocyclic group; A 2 is a benzene ring having up to 5 substituents in total; X is O, S or NR 1 [wherein R 1 is H, alkyl, acyl or alalkyl (an aryl part may be substituted) or (substituted) aryl]; Y is O or S but, when X is NR 1 , Y is not O; R 2 and R 3 are each H or combined to form a single bond; and n is 2-6}, its tautomer, its salt or its solvate. n EXAMPLE: 5-[4-((2-(2-Benzooxazolyl)oxy)ethoxy)benzyl]-2,4-thiazolidione. n USE: A treatment agent of hyperglycemia, hyperlipemia hypertension or a cordiovuscular system disease. n PROCESS: A compd. represented by formula II (wherein R z is H or a nitrogen protective group and R a is a group represented by formula III) and a reagent capable of converting the group; R a to the group represented by formula III are reacted. n COPYRIGHT: (C)1990,JPO
isCitedBy http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-9422246-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2013146932-A1
priorityDate 1988-08-26-04:00^^<http://www.w3.org/2001/XMLSchema#date>
type http://data.epo.org/linked-data/def/patent/Publication

Incoming Links

Predicate Subject
isDiscussedBy http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID458394811
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419556970
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID947
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID458394834

Total number of triples: 33.